ATE346593T1 - Pharmazeutische zusammensetzung zur perkutann absorption und verfahren für ihre herstellung - Google Patents

Pharmazeutische zusammensetzung zur perkutann absorption und verfahren für ihre herstellung

Info

Publication number
ATE346593T1
ATE346593T1 AT03012812T AT03012812T ATE346593T1 AT E346593 T1 ATE346593 T1 AT E346593T1 AT 03012812 T AT03012812 T AT 03012812T AT 03012812 T AT03012812 T AT 03012812T AT E346593 T1 ATE346593 T1 AT E346593T1
Authority
AT
Austria
Prior art keywords
pressure
sensitive adhesive
pharmaceutical preparation
adhesive layer
percutaneous absorption
Prior art date
Application number
AT03012812T
Other languages
English (en)
Inventor
Takateru Muraoka
Keigo Inosaka
Hiroko Ishitani
Yoshihisa Nakano
Original Assignee
Nitto Denko Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nitto Denko Corp filed Critical Nitto Denko Corp
Application granted granted Critical
Publication of ATE346593T1 publication Critical patent/ATE346593T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Adhesive Tapes (AREA)
AT03012812T 2002-06-05 2003-06-05 Pharmazeutische zusammensetzung zur perkutann absorption und verfahren für ihre herstellung ATE346593T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002164973A JP4323138B2 (ja) 2002-06-05 2002-06-05 経皮吸収型製剤およびその製造方法

Publications (1)

Publication Number Publication Date
ATE346593T1 true ATE346593T1 (de) 2006-12-15

Family

ID=29545811

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03012812T ATE346593T1 (de) 2002-06-05 2003-06-05 Pharmazeutische zusammensetzung zur perkutann absorption und verfahren für ihre herstellung

Country Status (9)

Country Link
US (1) US20030228354A1 (de)
EP (1) EP1369112B1 (de)
JP (1) JP4323138B2 (de)
AT (1) ATE346593T1 (de)
CA (1) CA2430857C (de)
DE (1) DE60309963T2 (de)
DK (1) DK1369112T3 (de)
ES (1) ES2275972T3 (de)
PT (1) PT1369112E (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI341735B (en) * 2003-07-31 2011-05-11 Hisamitsu Pharmaceutical Co Adhesive preparations
EP1682102A2 (de) * 2003-09-10 2006-07-26 Noven Pharmaceuticals, Inc. Mehrschichtige transdermale arzneimittelabgabevorrichtung
CA2542778C (en) * 2003-10-28 2012-05-29 Noven Pharmaceuticals, Inc. Transdermal drug delivery composition
JP4724368B2 (ja) 2004-01-07 2011-07-13 コスメディ製薬株式会社 粘着剤組成物および貼付剤
WO2006041911A2 (en) 2004-10-08 2006-04-20 Noven Pharmaceuticals, Inc. Device transdermal administration of drugs including acrylic polymers
US8343538B2 (en) * 2004-10-08 2013-01-01 Noven Pharmaceuticals, Inc. Compositions and methods for controlling the flux of a drug from a transdermal drug delivery systems
EP1847264B1 (de) * 2005-01-31 2017-05-03 Hisamitsu Pharmaceutical Co., Inc. Bisoprolol Pflaster
CA2548864C (en) * 2005-06-06 2012-12-11 Nitto Denko Corporation Percutaneous absorption-type pharmaceutical preparation
EP1731143B1 (de) * 2005-06-06 2008-11-26 Nitto Denko Corporation Pharmazeutische Zusammensetzung zur perkutane Absorption unter Verwendung von einem Metalchlorid, vorzugsweise Natriumchlorid, zur Vorbeugung von Kohäsionsschwäche
US9056061B2 (en) 2005-09-23 2015-06-16 Alza Corporation Transdermal nicotine salt delivery system
US8383149B2 (en) 2005-09-23 2013-02-26 Alza Corporation High enhancer-loading polyacrylate formulation for transdermal applications
EP1992363B1 (de) * 2006-02-28 2012-12-19 Hisamitsu Pharmaceutical Co., Inc. Transdermales absorptionspräparat
JP4988306B2 (ja) * 2006-11-01 2012-08-01 日東電工株式会社 医療用粘着剤及び医療用粘着テープ又はシート
US20100062045A1 (en) * 2006-12-01 2010-03-11 Nitto Denko Corporation Method for suppressing coloring of adhesive prepartion containing donepezil and method for reducing amounts of donepezil-related substances formed
RU2452474C2 (ru) 2006-12-01 2012-06-10 Нитто Денко Корпорейшн Стабилизированная адгезивная композиция, содержащая донепезил
CN102046171B (zh) * 2008-05-30 2013-06-19 日东电工株式会社 经皮吸收制剂
RU2481826C2 (ru) * 2008-05-30 2013-05-20 Нитто Денко Корпорейшн Содержащий донепезил адгезивный препарат и упаковка для него
US8231906B2 (en) 2008-07-10 2012-07-31 Noven Pharmaceuticals, Inc. Transdermal estrogen device and delivery
JP2011074035A (ja) * 2009-09-30 2011-04-14 Sekisui Medical Co Ltd 貼付剤
JP2014105205A (ja) * 2012-11-30 2014-06-09 Medical Front Co Ltd 医用貼付剤
CN115813888A (zh) 2016-12-20 2023-03-21 罗曼治疗系统股份公司 包含阿塞那平的透皮治疗系统
EP3558276B1 (de) 2016-12-20 2024-11-06 LTS Lohmann Therapie-Systeme AG Transdermales therapeutisches system mit asenapin und polysiloxan oder polyisobutylen
WO2019002204A1 (en) 2017-06-26 2019-01-03 Lts Lohmann Therapie-Systeme Ag TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING ASENAPINE AND SILICONE-TYPE ACRYLIC HYBRID POLYMER
AU2019291060B2 (en) 2018-06-20 2024-09-05 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine
US12329862B2 (en) 2018-06-20 2025-06-17 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4585452A (en) * 1983-04-12 1986-04-29 Key Pharmaceuticals, Inc. Transdermal systemic dosage forms
ATE59302T1 (de) * 1984-07-24 1991-01-15 Key Pharma Klebende schicht zur transdermalen freigabe.
US5045553A (en) * 1987-06-24 1991-09-03 Fujisawa Pharmaceutical Company, Ltd. Pharmaceutical composition for percutaneous drug absorption and percutaneous drug absorption promoter
DE3933460A1 (de) * 1989-10-06 1991-04-18 Lohmann Therapie Syst Lts Oestrogenhaltiges wirkstoffpflaster
CA2077369A1 (en) * 1991-09-09 1993-03-10 Hitoshi Akemi Acrylic gel material and gel-based medical preparation for percutaneous absorption employing the same
US5462746A (en) * 1992-11-02 1995-10-31 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Patch for transdermal administration of volatile pharmaceutically active ingredients of chemically basic nature and a process for preparation
US5503843A (en) * 1994-04-22 1996-04-02 Flora Inc. Transdermal delivery of alpha adrenoceptor blocking agents
JP3576608B2 (ja) * 1994-11-15 2004-10-13 日東電工株式会社 貼付剤および貼付製剤
US5601839A (en) * 1995-04-26 1997-02-11 Theratech, Inc. Triacetin as a penetration enhancer for transdermal delivery of a basic drug
US6348210B1 (en) * 1998-11-13 2002-02-19 Alza Corporation Methods for transdermal drug administration
JP4358978B2 (ja) * 2000-09-05 2009-11-04 日東電工株式会社 経皮吸収製剤

Also Published As

Publication number Publication date
DK1369112T3 (da) 2007-02-26
PT1369112E (pt) 2007-02-28
DE60309963T2 (de) 2007-03-08
JP2004010525A (ja) 2004-01-15
CA2430857C (en) 2011-01-25
CA2430857A1 (en) 2003-12-05
DE60309963D1 (de) 2007-01-11
EP1369112B1 (de) 2006-11-29
EP1369112A1 (de) 2003-12-10
JP4323138B2 (ja) 2009-09-02
US20030228354A1 (en) 2003-12-11
ES2275972T3 (es) 2007-06-16

Similar Documents

Publication Publication Date Title
ATE346593T1 (de) Pharmazeutische zusammensetzung zur perkutann absorption und verfahren für ihre herstellung
AU2003219744A1 (en) A micro-channeled protective film
ATE485258T1 (de) Glycyrrhetinsäurederivate und ihre verwendung zur herstellung eines medikaments zur hemmung der 11- beta-hydroxysteroid dehydrogenase
AU2002361107A1 (en) Medical pressure-sensitive adhesive composition, process for producing the same, and medical tape
ATE409213T1 (de) Druckempfindliche acrylatklebstoffzusammensetzung und druckempfindliches klebeband
AU2003295705A1 (en) B-stageable die attach adhesives
DE60233420D1 (de) Fumagillolderivate und verfahren zu deren herstellung
DK1079813T3 (da) Farmaceutisk bæreranordning, der er egnet til administration af farmaceutiske forbindelser til slimhindeoverflader
BR0309546A (pt) Composto, composição farmacêutica que compreende o mesmo, processo para a sua preparação e utilização e método para tratamento profilático ou terapêutico de diabetes do tipo ii
WO2004037181A3 (en) Glycinenitrile-based inhibitors of dipeptidyl peptidase iv and methods
DE60333715D1 (de) Verfahren zur Herstellung funktioneller Substrate, die kolumnare Mikrosäulen aufweisen
WO2007044647A3 (en) Pressure bandage with medication delivery system
DE50301421D1 (de) UV-härtender schmelzklebstoff
CA2423164A1 (en) Procedure and device for sticking objects
WO2004050115A3 (en) Combination treatment using exendin-4 and thiazolidinediones
ATE466008T1 (de) P-glycoprotein-inhibitor, verfahren zu dessen herstellung und pharmazeutische zusammensetzung, die diesen enthält
DE50212267D1 (de) Transdermales therapeutisches system für die verabreichung carboxylgruppenhaltiger, nichtsteroidaler antiphlogistika, sowie verfahren zu seiner herstellung
ATE517616T1 (de) Faserfreies transdermales therapeutisches system und verfahren zu seiner herstellung
IL176152A0 (en) Percutaneous absorption-type pharmaceutical preparation
MY154939A (en) Cover tape and method for manufacture
ATE86127T1 (de) Praeparat fuer die perkutane absorption und verfahren zu dessen herstellung.
AR050837A1 (es) Composiciones para recubrir y metodos para recubrir sustratos
DE60303326D1 (de) Transdermalpflaster und Verfahren zu dessen Herstellung
ATE372766T1 (de) Pflaster und verfahren zu seiner herstellung
DE602006003818D1 (de) Pharmazeutische Zusammensetzung zur perkutane Absorption unter Verwendung von einem Metalchlorid, vorzugsweise Natriumchlorid, zur Vorbeugung von Kohäsionsschwäche

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1369112

Country of ref document: EP